Dietary selenium and selenoprotein function

Medical Science Monitor

Volumn 18, Issue 8, 2012, Pages

  Weeks, Benjamin S ^a   Hanna, Mirna S ^a   Cooperstein, Deborah ^a  

^a ADELPHI UNIVERSITY   (United States)

Author keywords

Antioxidant; Dietary; Se; Selenium; Selenoproteins

Indexed keywords

SELENIUM; SELENOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CANCER PREVENTION; CEREBROVASCULAR ACCIDENT; DIETARY INTAKE; FERTILITY; HEART DISEASE; HUMAN; INTRAVENOUS FEEDING; NERVE DEGENERATION; NONHUMAN; SELENIUM DEFICIENCY; THYROID FUNCTION;

EID: 84866066548     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883258     Document Type: Article

References (76)

1. Kryukov GV, Castellano S, Novoselov SV et al: Characterization of mammalian selenoproteomes. Science, 2003; 300(5624): 1439-43
2. Baliga MS, Wang H, Zhuo P et al: Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage. Biol Trace Elem Res, 2007; 115(3): 227-42
3. Carlson BA, Xu XM, Gladyshev VN, Hatfield DL: Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J Biol Chem, 2005; 280(7): 5542-48
4. Chu FF, Esworthy RS, Chu PG et al: Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res, 2004; 64(3): 962-68
5. Banning A, Kipp A, Schmitmeier S et al: Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice. Cancer Res, 2008; 68(23): 9746-53
6. Cooper ML, Adami HO, Gronberg H et al: Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res, 2008; 68: 10171-77
7. Gresner P, Gromadzinska J, Jablonska E et al: Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer, 2009; 65(1): 34-40
8. Cheng WH, Ho YS, Valentine BA et al: Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr, 1998; 128: 1070-76
9. de Haan JB, Bladier C, Griffiths P et al: Mice with a homozygous null mutation for the most abundant glutathione peroxidase, GPx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem, 1998; 273: 22528-36
10. Beck MA, Esworthy RS, Ho YS, Chu FF: Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J, 1998; 12: 1143-49
11. Trépanier G, Furling D, Puymirat J, Mirault ME: Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain. Neuroscience, 1996; 75(1): 231-43
12. Lindenau J, Noack H, Asayama K, Wolf G: Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration. Glia, 1998; 24(2): 252-56
13. Power JH, Blumbergs PC: Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol, 2009; 117(1): 63-73
14. Blackinton J, Kumaran R, van der Brug MP et al: Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neurosci Lett, 2009; 452(1): 8-11
15. Seiler A, Schneider M, Forster H et al: Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependentand AIF-mediated cell death. Cell Metab, 2008; 8: 237-48
16. Chen L, Na R, Gu M et al: Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. J. Neurochem, 2008; 107: 197-207
17. Yant LJ, Ran Q, Rao L et al: The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med, 2003; 34: 496-50218
18. Imai H, Hirao F, Sakamoto T et al: Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun, 2003; 305: 278-86
19. Ufer C, Wang CC, Fahling M et al: Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. Genes Dev, 2008; 22: 1838-50
20. Valentine WM, Abel TW, Hill KE et al: Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2. J Neuropathol Exp Neurol, 2008; 67: 68-77
21. Bellinger FP, He QP, Bellinger MT et al: Association of selenoprotein p with Alzheimer's pathology in human cortex. J Alzheimers Dis, 2008; 15: 465-72
22. Freedman JE, Loscalzo J, Benoit SE et al: Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest, 1996; 97: 979-87
23. Kenet G, Freedman J, Shenkman B et al: Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler Thromb Vasc Biol, 1999; 19: 2017-23
24. Voetsch B, Jin RC, Bierl C et al: Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke, 2007; 38: 41-49
25. Voetsch B, Jin RC, Bierl C et al: Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke, 2008; 39: 303-7
26. Guo Z, Ran Q, Roberts LJ II et al: Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic Biol Med, 2008; 44: 343-52
27. Alanne M, Kristiansson K, Auro K et al: Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts. Hum Genet, 2007; 122: 355-65
28. Silander K, Alanne M, Kristiansson K et al: Gender differences in genetic risk profiles for cardiovascular disease. PLoS ONE, 2008; 3: e3615
29. Bianco AC, Salvatore D, Gereben B et al: Biochemistry, cellular and molecularbiology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev, 2002; 23: 38-89
30. Schneider MJ, Fiering SN, Pallud SE et al: Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol, 2001; 15: 2137-48
31. de Jesus LA, Carvalho SD, Ribeiro MO et al: The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest, 2001; 108: 1379-85
32. Schmutzler C, Mentrup B, Schomburg L et al: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol Chem, 2007; 388: 1053-59
33. Dumitrescu AM, Liao XH, Abdullah MS et al: Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet, 2005; 37: 1247-52
34. Ursini F, Heim S, Kiess M et al: Dual function of the selenoprotein PHGPx during sperm maturation. Science, 1999; 285: 1393-96
35. Foresta C, Flohe L, Garolla A et al: Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase. Biol Reprod, 2002; 67: 967-71
36. Schomburg L, Schweizer U, Holtmann B et al: Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J, 2003; 370: 397-402
37. Imai H, Hirao F, Sakamoto T et al: Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun, 2003; 305: 278-86
38. Ufer C, Wang CC, Fahling M et al: Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. Genes Dev, 2008; 22: 1838-50
39. Conrad M, Jakupoglu C, Moreno SG et al: Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol, 2004; 24: 9414-23
40. Jurynec MJ, Xia R, Mackrill JJ et al: Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc Natl Acad Sci USA, 2008; 105: 12485-90
41. Grumolato L, Ghzili H, Montero-Hadjadje M et al: Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J, 2008; 22: 1756-68
42. Beck MA, Shi Q, Morris VC, Levander OA: Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Medicine, 1995; 1: 433-36
43. Beck MA, Esworthy RS, Ho Y-S, Chu F-F: Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J, 1998; 12: 1143-49
44. Beck MA, Handy J, Levander OA: Host nutritional status: the neglected virulence factor. Trends Microbiol, 2004; 12: 417-23
45. Gladyshev VN, Stadtman TC, Hatfield DL, Jeang KT: Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc Natl Acad Sci USA, 1999; 96: 835-39
46. Kalantari P, Narayan V, Natarajan SK et al: Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages. J Biol Chem, 2008; 283: 33183-90
47. Baum MK, Shor-Posner G, Lai S et al: High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol, 1997; 15(5): 370-74
48. Campa A, Shor-Posner G, Indacochea F et al: Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol, 1999; 20: 508-13
49. Burbano X, Miguez-Burbano MJ, McCollister K et al: Impact of a selenium chemoprevention clinical trial on hospital admissions of HIVinfected participants. HIV Clin Trials, 2002; 3: 483-91
50. Odonukwe NN: The role of Se as adjunct to HAART among HIV-infected individuals who are advanced in their disease. Sixteenth International AIDS Conference 2006, Toronto, Canada. MoAb0403
51. Clark LC, Combs GF Jr, Turnbull BW et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 1996; 276(24): 1957-63. Erratum in: JAMA, 1997; 277(19): 1520
52. Combs GF Jr, Clark LC, Turnbull BW: Reduction of cancer mortality and incidence by selenium supplementation. Med Klin (Munich), 1997; 92(Suppl.3): 42-45
53. Clark LC, Dalkin B, Krongrad A et al: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 1998; 81(5): 730-34
54. Duffield-Lillico AJ, Reid ME, Turnbull BW et al: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev, 2002; 11(7): 630-39
55. Duffield-Lillico AJ, Dalkin BL, Reid ME et al, Nutritional Prevention of Cancer Study Group: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int, 2003; 91(7): 608-12
56. Reid ME, Duffield-Lillico AJ, Sunga A et al: Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer, 2006; 118(7): 1777-81
57. Dziaman T, Huzarski T, Gackowski D et al: Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer Epidemiol Biomarkers Prev, 2009; 18(11): 2923-28
58. Vidlar A, Vostalova J, Ulrichova J et al: The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy-a six month placebo-controlled double-blind clinical trial. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2010; 154(3): 239-44
59. Sieja K: Selenium (Se) deficiency in women with ovarian cancer undergoing chemotherapy and the influence of supplementation with this micro-element on biochemical parameters. Pharmazie, 1998; 53(7): 473-76
60. Muecke R, Schomburg L, Glatzel M et al, German Working Group Trace Elements and Electrolytes in Oncology-AKTE: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys, 2010; 78(3): 828-35
61. Büntzel J, Micke O, Kisters K et al: Selenium substitution during radiotherapy of solid tumours-laboratory data from two observation studies in gynaecological and head and neck cancer patients. Anticancer Res, 2010; 30(5): 1783-86
62. Kiremidjian-Schumacher L, Roy M, Wishe HI et al: Supplementation with selenium and human immune cell functions. Biol Trace Elem Res, 1994; 41: 115-27
63. Spallholz JE, Boylan LM, Larsen HS: Advances in understanding selenium's role in the immune system. Ann NY Acad Sci, 1990; 587: 123-39
64. Broome CS, McArdle F, Kyle JA et al: An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr, 2004; 80: 154-62
65. Kiremidjian-Schumacher L, Roy M, Glickman R et al: Selenium and immunocompetence in patients with headand neck cancer. Biol Trace Elem Res, 2000; 73: 97-111
66. Gärtner R, Gasnier BC, Dietrich JW et al: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab, 2002; 87(4): 1687-91
67. Marcocci C, Kahaly GJ, Krassas GE et al, European Group on Graves Orbitopathy Selenium and the course of mild Graves orbitopathy. N Engl J Med, 2011; 364(20): 1920-31
68. Ricketts JR, Rothe MJ, Grant-Kels JM: Nutrition and psoriasis. Clin Dermatol, 2010; 28(6): 615-26
69. Bogye G, Alfthan G, Machay T, Zubovics L: Enteral yeast-selenium supplementation in preterm infants. Arch Dis Child Fetal Neonatal Ed, 1998; 78(3): F225-26
70. Bogye G, Alfthan G, Machay T: Randomized clinical trial of enteral yeast-selenium supplementation in preterm infants. Biofactors, 1998; 8(1-2): 139-42
71. Scott R, MacPherson A, Yates RW et al: The effect of oral selenium supplementation on human sperm motility. Br J Urol, 1998; 82(1): 76-80
72. Tara F, Rayman MP, Boskabadi H et al: Selenium supplementation and premature (pre-labour) rupture of membranes: a randomised doubleblind placebo-controlled trial. J Obstet Gynaecol, 2010; 30(1): 30-34
73. Tara F, Maamouri G, Rayman MP et al: Selenium supplementation and the incidence of preeclampsia in pregnant Iranian women: a randomized, double-blind, placebo-controlled pilot trial. Taiwan J Obstet Gynecol, 2010; 49(2): 181-87
74. Benton D, Cook R: Selenium supplementation improves mood in a double-blind crossover trial. Psychopharmacology (Berl), 1990; 102(4): 549-50
75. Benton D, Cook R: The impact of selenium supplementation on mood. Biol Psychiatry, 1991; 29(11): 1092-98
76. Mokhber N, Namjoo M, Tara F et al: Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial. J Matern Fetal Neonatal Med, 2011; 24(1): 104-8